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Abstract: The enantioselective formation of nitroprolinates followed 
by diastereoselective Michael-type addition onto a second unit of the 
nitro alkene is studied. The reaction occurred in a one pot-sequential 
process controlled by the chiral phosphoramidite·silver benzoate 
complex. The origin of the high diastereoselectivity is studied by DFT 
computational analysis where the crucial effect of the benzoic acid is 
justified. The employment of this strategy to the preparation of 
pyrazine-2-ones is also surveyed, as well as the preparation of 
diketopiperazines from enantiomerically enriched exo-prolinates 
using conventional N-acylation-amination-cyclization steps. 
Introduction 
Nitroprolinates constitute a small series of compounds whose 
importance in many scientific areas has recently been 
demonstrated.[ 1 ] For example, optically active polysubstituted 
nitroprolinates 1 (Figure 1) are important inhibitors of α4,β1-
integrin-mediated hepatic melanoma and in a murine model of 
colon carcinoma metastasis, as well as potent antiadhesive 
properties in several cancer cell lines.[2,3] Bicyclic heterocycles 2, 
have been found as inhibitors of skin cancer.[4]  Spiroxindoles 3 
increased the mortality of zebrafish embryos,[5] and molecules 4 
were tested as antimycobacterials against M. tuberculosis H37Rv 
strain.[6] A family of enantiomerically enriched spironitroprolinates 
5 were obtained by our group from imino lactones and 
nitroalkenes which are currently tested as anticancer agents.[7] 
The presence of the nitro group in this skeleton induced special 
conformations of the five membered ring causing spectacular 
effects in its biological activity and its chemical reactivity.[8]  
 Diastereomeric exo-6 and endo-6  4-nitroprolinates have 
been used as chiral organocatalysts in aldol reactions.[9] endo-6 
Preferentially promoted the polymerization of D-lactide, whereas 
exo-6 preferentially polymerized L-lactide from a racemic 
mixture.[10] Michael-type addition of ketones to nitroalkenes[11] and 
a three component ketone-carboxylic acid-nitroalkene 
cyclization[12] were successfully organocatalyzed by chiral exo-6b 
(X = H), providing good to excellent diastereoselections and high 
enantiomeric ratios. A series of enantiopure tetrasubstituted 
nitroprolinate surrogates has been designed as scaffolds for 
proteasome inhibitors with high medicinal prospects.[ 13 ]  In 
addition, the NH-D-EhuPhos ligand 7 has been efficiently 
employed in the 1,3-dipolar cycloadditions (1,3-DC) to yield 
nitroprolinates and structurally rigid spirocompounds from chiral 
γ-lactams.[9, 14 , 15 ] exo-6a Series were employed as amino 
component in the multicomponent amino-aldehyde-dienophile 
(AAD)[8] reaction affording chiral cyclohex-2-enyl amines and in 





Figure 1. Nitroprolinates with biological properties and utility in organic 
synthesis.  
 
 According to the experience of our group in the synthesis[7] 
of the enantiomerically enriched nitroprolinates 6,[17,18] and the 
reactivity exhibited by the amino moiety of these structures 6-7, 
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pyrrolidines 6. So, in this work we studied the scope and the 
stereochemical course of the one pot process starting from imino 
ester 9a and 8a to yield compound 10a (Scheme 1), avoiding the 
isolation of intermediate exo-6a. That means, performing a 
domino enantioselective pyrrolidine formation-diastereoselective 
Michael addition onto the nitroalkene to provide the 
corresponding adducts, which can be further transformed into 
fused nitropyrrolidine-heterocycles. The support of DFT 
calculations to the mechanistic outcomes, as well as additions of 
other Michael-type acceptors will be surveyed.  In addition, N-
acylations of 6 with -chloroacetyl chlorides to provide fused 
nitropyrrolidine-diketopiperazines will be discussed. 
 
 
Scheme 1. Design of the synthesis of Michael-type adducts 10 in one pot 
process from imino ester 9a for the preparation of fused nitropyrrolidino-
pyrazinones and of its acylation for the synthesis of nitropyrrolidino-
diketopiperazines. 
Results and Discussion 
 Initially, we employed the conditions for the synthesis of 
enantiomerically enriched exo-6 compounds, described by our 
group, but using two equivalents of nitrostyrene. The optimization 
is briefly summarized in Table 1. Despite the reaction was 
observed in the presence of the reagents involved in the synthesis 
of exo-cycloadduct 6, we first tried to perform the reaction of pure 
exo-6a with β-nitrostyrene (8a) but no reaction product was 
detected. So, the chiral silver complex has a crucial effect not only 
in the synthesis of the chiral prolinate but in the Michael-type 
addition.[ 19 ] Basic conditions promoted the retro-Michael type 
addition obtaining pure exo-6a cycloadduct (Table 1, entry 1). The 
addition of several amounts of benzoic acid resulted to be 
beneficial, the highest amount of acid the highest yield of 10a was 
isolated (Table 1, entries 2 and 3). The replacement of benzoic 
acid by acetic acid was not productive lowering the percentage of 
10a (Table 1, entry 4). The addition of 1.5 or 2.0 equiv of benzoic 
acid instead of 1 equiv did not improve the results of the reaction. 
 




entry additive (equiv) 6a:10a[a] yield of 10a (%)[b]  10a dr [c] 
1 --- >98:2 --- nd 
2 BzOH (0.5) 50:50 nd >98:2 
3 BzOH (1) <2:98 84% >98:2 
4 AcOH (1) 35:65 nd >98:2 
a Determined by 1H NMR of the crude reaction mixture. b Isolated yield after flash 
chromatography. Mixture of 4 diastereomers. c Determined by 1H NMR of the 
crude reaction mixture and in the final purified sample. 
 
The absolute configuration of the new stereogenic center 
was unambiguously determined by both X-ray diffraction analysis 
and also by vibrational circular dichroism (VCD). In both cases the 
structure of compound 10a matched with a (S)-configuration[20] 
(see SI).  
 In the presence of benzoic acid (1 equiv) at rt during 17 h 
products 10 were satisfactorily obtained with a very high 
diastereoselectivity (Figure 2). For compounds 10a,c and 10e the 
same nitroalkene was employed for both enantioselective 
cycloaddition and Michael-type addition. However, it was also 
possible to introduce a different nitroalkene once the 
enantioselective cycloaddition took place (Figure 2, products 
10b,d). In these examples only one equivalent of nitroalkene was 
needed in the first step, meanwhile the other different nitroalkene 
(8a, 1 equiv) was added together with the benzoic acid after 17 h. 
Despite many attempts and combinations of structural 
parameters in all components of the reaction, the scope was 
reduced to those examples shown in Figure 2.   
 The high influence of the chiral silver catalyst in both the 
1,3–DC and the Michael addition was analyzed by means of DFT 
calculations. Within the accepted 1,3–DC reaction mechanism 
(Scheme 2), the last step consists in the reaction of the silver–
pirrolidine INT3 with fresh imine 9a to recover the initial 
azomethine ylide INT1[ 21 ] and generate final product exo–6a 
(Scheme 2, see SI for further details about 1,3–DC analysis). We 
hypothesize that exo–6a formation is an irreversible step, and 
therefore, it is not possible to form INT3 (and consequently 10a) 
by using exo–6a as starting reagent. In fact, the reaction of 
isolated exo–6a, chiral silver(I) complex, β-nitrostyrene 8a, and 
benzoic acid did not occur. So, the experimental evidences 
support that presence of small amounts of INT3 in this sequential-




Figure 2. Compounds 10 isolated and characterized. 
 
 We postulate that INT3 can further react with the excess of 
β-nitrostyrene in the absence of benzoic acid to ultimately form 
compound 10a (Scheme 2, route a). Within this route, our 
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(0.3 kcal·mol-1) and the Gibbs’ barrier activation is of 9.6 kcal·mol-
1 (see SI for further details). These results indicate that formation 
of 10a by merely adding a second equivalent of β-nitrostyrene to 
the reaction mixture is not a kinetically favored reaction.  
 In addition, we also analyzed computationally the effect of 
adding benzoic acid (Scheme 2, route b). In this case, the additive 
effect is twofold: firstly, the phenyl ring of benzoic acid interacts 
with the aromatic rings of the ligand. This -stacking interaction 
strongly stabilizes RC2’ (see SI).[22] Moreover, it enhances β-
nitrostyrene electrophilicity (as reflected with the lower activation 
barrier of TS3’ compared to TS3). Remarkably, both factors 
prompt 10a formation.[23] 
 Exploration of all the possible transition structures 
associated with the Michael addition step showed the preferential 
reactivity of the S–prochiral face of β-nitrostyrene. The high 
selectivity can be attributed to the favourable NO2–Ag interaction 
(associated with an inward approach of the former) and a 
stabilizing -stacking interaction in TS3’PRO–S (similar to those 
found in RC2’) that are not present neither in TS3’PRO–R (Figure 3) 
nor in the reaction performed with acetic acid. Note that the 
relevance of the counteranion in the coordination sphere of the 
silver atom on the 1,3–DC selectivity was previously assessed.[16a]  
 Therefore, the calculations predict the preferential formation 
of compound 10a with a theoretical dr of >99% when using 
benzoic acid as additive, in excellent agreement with the 
experimental results. 
 Another Michael-type addition was successfully tested 
following the same sequential strategy (Scheme 3). Methyl vinyl 
ketone afforded product 11 in 78% yield, but acrylates did not 
work. To overcome this problem a stabilizing group was attached 
to the electron-withdrawing entity in order to avoid the retro-
addition. Thus, compounds 12 and 13 could be isolated in 62% 
and 71% yields, respectively. An identical situation was observed 
when 1,1-bis(phenylsulfonyl)ethylene was allowed to react under 
these optimized conditions furnishing product 14 in 72% yield. 
Electron-deficient alkynes were also suitable Michael acceptors 
such as it was demonstrated in the reactions with dimethyl 
acetylenedicarboxylate and but-3-in-2-one. All these products 11-
16 were very sensitive to silica-gel purification, so they were 
isolated from recrystallization from the crude reaction mixtures. 
Relative configuration of compounds 15 and 16 was determined 
by nOe experiments (see SI). Again, the reactions between 
starting nitroprolinate exo-6a with all these Michael-type 
acceptors were unsuccessful.  
As useful application of the structure 10a we envisaged the 
possibility to prepare hexahydropyrrolo[1,2-a]pyrazin-1(2H)-ones. 
For the preparation of bicyclic δ-lactam 18, compound 10a was 
treated with Zn (dust) in the presence of concentrated aqueous 
HCl (37%) in ethanol at 60 ºC for 15 min[24] (Scheme 4) affording 
the diamine 17 in 87% yield. The cyclization in methanolic KOH 
was achieved to generate 18 in 89% yield. In both transformations 




Scheme 2. Proposed catalytic cycles associated with the 1,3–DC and Michael 
reaction. Relative and activations Gibbs free energies computed at 
M06(PCM)/6-311+G**&LANL2DZ// ONIOM(B3LYP/6-31G*&LANL2DZ:UFF) 






Figure 3. Main geometrical features and relative Gibbs Free energies of 
transition structures associated with the Michael addition step in presence of 
benzoic acid as additive computed at M06(PCM)/6-311+G**&LANL2DZ// 
ONIOM(B3LYP/6-31G*&LANL2DZ:UFF) level. Second molecule of -
nitrostyrene and the additive are highlighted in green. Relative Gibbs free 
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Scheme 3. Sequential enantioselective synthesis of nitroprolinates-Michael 
type addition. 
 
   
  
 
Scheme 4. Synthesis of enantiomerically enriched pyrazine-2-one 18. 
 
 
 Besides, 2,5-diketopiperazines, a family of very interesting 
compounds,[25] were readily prepared from exo-6a and α-chloro 
acyl chlorides in very good yields[26] (Scheme 5). The mixture of 
diastereoisomers 20 and 21 could be separated and 
independently cyclized employing aqueous methylamine. Their 
absolute configuration was unambiguously determined according 






Scheme 5. Synthesis of diketopiperazines 19, 22 and 23. 
Conclusion 
 In conclusion, the enantioselective cycloaddition 
→diastereoselective Michael-type domino process was 
satisfactorily controlled. It was demonstrated the crucial effect 
shown by the chiral phosphoramidite/silver benzoate complex in 
the almost total diastereoselective control in the Michael-type 
addition of the intermediate chiral silver prolinamide onto a 
second unit of β-nitrostyrene. The retro-Michael step can be 
controlled despite of the lower energetic barrier to yield starting 
cycloadduct. The presence and position of the benzoic acid is 
crucial for the activation of the nitroalkene. Its extra π-interaction 
with the aromatic part of the chiral ligand, together with the 
repulsive Pauling interaction between the nitro group of β-
nitrostyerne and the carboxy moiety of the pyrrolidine ring favour 
the matching TS arrangement. The scope of this reaction is 
limited due to the scarce energy gap between the both associated 
cycles operating simultaneously, which can be more similar 
depending on the nature of the substituents in both the dipole and 
the dipolarophile. This methodology allows the diastereoselective 




General: All commercially available reagents and solvents were 
used without further purification, only aldehydes were also 
distilled prior to use. Analytical TLC was performed on Schleicher 
& Schuell F1400/LS 254 silica gel plates, and the spots were 
visualized under UV light (λ = 254 nm). Melting points were 
determined with a Reichert Thermovar hot plate apparatus and 
are uncorrected. Optical rotations were measured on a JASCO P-
1030 polarimeter with a thermally jacketed 5 cm cell at 
approximately 25 ̊ C and concentrations (c) are given in g/100 mL. 
The structurally most important peaks of the IR spectra (recorded 
using a Nicolet 510 P-FT) are listed and wavenumbers are given 
in cm-1. NMR spectra were obtained using a Bruker AC-300 or 
AC-400 and were recorded at 300 or 400 MHz for 1H NMR and 
75 or 100 MHz for 13C NMR, using CDCl3 as solvent and TMS as 
internal standard (0.00 ppm) unless otherwise stated. The 
following abbreviations are used to describe peak patterns where 
appropriate: s = singlet, d = doublet, t = triplet, q = quartet, dd = 
doublet of doublets, m = multiplet or unresolved and br s = broad 
signal. All coupling constants (J) are given in Hertz (Hz) and 
chemical shifts in ppm. 13C NMR spectra were referenced to 
CDCl3 at 77.16 ppm. Low-resolution electron impact (EI) mass 
spectra were obtained at 70 eV using a Shimadzu QP-5000 by 
injection or DIP; fragment ions in m/z are given with relative 
intensities (%) in parentheses. High-resolution mass spectra 
(HRMS) were measured on an instrument using a quadrupole 
time-of-flight mass spectrometer (QTOF) and also through the 
electron impact mode (EI) at 70 eV using a Finnigan VG Platform 
or a Finnigan MAT 95S. Vibrational Circular Dichroism (VCD) 
studies were accomplished in a Jasco FVS-6000 and X-ray 
crystal structure was determined using a Bruker CCD-Apex. 
 
General procedure A: Synthesis of Michael adducts (10-16): 
Silver benzoate (5 mol%, 0.026 mmol, 5.9 mg) and (Sa,R,R)-L (6 
mol%, 0.03 mmol, 17.1 mg) were dissolved in toluene (5 mL). 
After 1 hour stirring the α-imino ester (136 mg, 0.53 mmol) and 
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nitrostyrene (1 equiv, 80 mg) was introduced and the reaction 
mixture was left to stir for 17 hours. Next, benzoic acid (1 equiv, 
64.7 mg) and the corresponding Michael acceptor (1.1 equiv) 
were added to the solution. The mixture was stirred 17 hours. The 
crude was filtered through a pad of celite and the filter was 
washed with EtOAc (15 mL). The corresponding solution was 
concentrated under reduced pressure and the purification step 
depended on the compound (see characterization data).  
 
General procedure B: Nitro group reduction (17): A round bottom 
flask was charged with the Michael adduct 10a (47.5 mg, 0.1 
mmol), zinc powder (261.52 mg, 4 mmol) and ethanol (3 mL). The 
corresponding suspension was heated to 60 ᵒC and the 
hydrochloric acid (37% aq., 0.5 mL) was added drop wise 
observing formation of hydrogen. The mixture was checked by 
TLC until completion of the reaction (15 minutes). The solvent was 
removed under reduced pressure and the grey solid was washed 
with saturated aqueous potassium carbonate until pH 10 and 
extracted with dichloromethane (8 mL) three times. The combined 
organic layers were dried over MgSO4 and concentrated under 
reduced pressure obtaining a white solid after 
precipitation/recrystallization (CH2Cl2/n-Hexane). 
 
General procedure C: Formation of δ-lactam 18: A round bottom 
flask was charged with 17 (41.5 mg, 0.1 mmol) in a 4 M solution 
of KOH/MeOH (2 mL). The mixture was stirred at room 
temperature for 20 hours and the crude mixture was concentrated 
under reduced pressure, washed with water and extracted with 
dichloromethane three times. The combined organic layers were 
dried over MgSO4 and the solvent was removed under vacuum 
obtaining a single diastereoisomer, as a white solid, that was 
purify by precipitation with CH2Cl2/n-hexane. 
 
General procedure D: Formation of diketopiperazine 19 (Method 
D.1): To a solution of exo-6a[17] (0.5 mmol, 163 mg) and 
triethylamine (1.5 equiv, 0.75 mmol, 105 µL) in dichloromethane 
(10 mL) at 0 ºC was added chloroacetyl chloride (1.5 equiv, 0.75 
mmol, 60 µL). The reaction was stirred for 30 min. at 0 ºC and 
warmed to room temperature. After being stirred for another 1 
hour, the reaction mixture was quenched with water (10 mL) and 
extracted three times with dichloromethane. The combined 
organic layers were dried over MgSO4 and concentrated under 
reduce pressure. The crude mixture obtained was dissolved in 
dichloromethane (10 mL) follow by the addition of methylamine 
(40% aq., 4 mL). The mixture was stirred overnight. The resulting 
yellow solution was quenched with water (10 mL) and extracted 
three times with dichloromethane. The combined organic layers 
were dried over MgSO4 and concentrated under reduce pressure. 
The desired product was obtained without purification. 
 
General procedure D: Formation of diketopiperazines 22 and 23 
(Method D.2): To a solution of exo-6a (0.18 mmol, 60 mg)[17] and 
triethylamine (1.5 equiv, 38 µL) in dichloromethane (4 mL) at 0 ºC 
was added 2-chloropropionylchloride (1.5 equiv, 27 µL) The 
reaction was stirred for 30 min. at 0 ºC and warmed to room 
temperature. After being stirred for another 2 hours, the reaction 
mixture was quenched with water (4 mL) and extracted three 
times with dichloromethane. The combined organic layers were 
dried over MgSO4 and concentrated under reduce pressure. The 
crude mixture was purified by column chromatography 
(Hx:EtOAc; 9:1 to 7:3) obtaining both diastereoisomers (dr = 
60:40). Each diastereoisomer (50 mg, 0.12 mmol) was dissolved 
in dichloromethane (3 mL) follow by the addition of methylamine 
(40% aq., 1.5 mL). The mixture was stirred overnight. The 
resulting yellow solution was quenched with water (3 mL) and 
extracted three times with dichloromethane. The combined 
organic layers were dried over MgSO4 and concentrated under 
reduce pressure. The desired products were obtained by 
purification by column chromatography (Hx:EtOAc; 7:3). 
 
(2S,3S,4R,5S)-Methyl 4-nitro-1-[(S)-2-nitro-1-phenylethyl]-
3,5-diphenylpyrrolidine-2-carboxylate (10a). White solid (211 
mg, 84% yield, de: 95%); precipitation with EtOAc:Et2O; mp: 154-
158 °C; [𝛼]𝐷
26 = 51.2 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3) δH: 
3.41 (s, 3H, CO2CH3), 3.84 (dd, J = 11.5, 9.8 Hz, 1H, NCHCHPh), 
4.29 (d, J = 9.8 Hz, 1H, CHCO2Me), 4.62-4.44 (m, 3H, CH2, 
NCHCHNO2), 4.85 (dd, J = 12.1, 9.1 Hz, 1H, NCHCH2NO2), 5.54 
(dd, J = 11.5, 8.8 Hz, 1H,CHNO2), 7.08-7.14 (m, 2H, ArH), 7.22-
7.28 (m, 5H, ArH), 7.44-7.60 (m, 8H, ArH) ppm; 13C NMR (CDCl3) 
δC: 51.2 (NCHCHPh), 52.2 (OCH3), 60.6 (NCHPh), 63.4 (NCHPh), 
70.3 (CCO2Me), 77.4 (CH2NO2), 91.8 (CHNO2), 127.9, 128.0, 
128.3, 128.9, 129.5, 129.6, 129.7, 129.9, 132.4, 136.7 (ArC), 
172.1 (CO2Me) ppm; IR (ATR) 𝜐𝑚𝑎𝑥 : 1743, 1552, 1376, 1195, 
1140 cm-1; MS (EI): m/z 429 (M+-NO2, <2%), 417 (16), 416 (63), 
370 (21), 369 (80), 279 (12), 221 (18), 220 (100), 219 (36), 194 
(14), 193 (80), 191 (13), 178 (19), 117 (22), 116 (16), 115 (58), 
105 (13), 104 (79), 103 (17), 102 (11), 91 (27), 77 (20); HRMS 




White solid (174 mg, 65% yield, de: 95%); precipitation with 
EtOAc:Et2O; mp: 162-167 °C; [𝛼]𝐷
28 = 83.2 (c 1, CHCl3); 1H NMR 
(300 MHz, CDCl3) δH: 3.45 (s, 3H, CO2CH3), 3.74 (s, 3H, COCH3), 
4.24 (d, J = 9.8 Hz, 1H, CHCO2Me), 4.44-4.59 (m, 3H, CH2, 
NCHCHNO2), 4.80 (dd, J = 12.2, 9.3 Hz, 1H, NCHCH2NO2), 5.49 
(dd, J = 11.6, 8.8 Hz, 1H,CHNO2), 6.77-7.02 (m, 2H, ArH), 7.02-
7.22 (m, 2H, ArH), 7.22-7.24 (m, 2 H, ArH), 7.46-7.56 (m, 8H, ArH) 
ppm; 13C NMR (CDCl3) δC: 50.81 (NCHCHPh), 52.2 (OCH3), 55.4 
(PhOCH3), 60.6 (NCHPh), 63.5 (NCHPh), 70.2 (CCO2Me), 77.2 
(CH2NO2), 92.2 (CHNO2), 114.4, 124.2, 128.0, 128.4, 129.2, 
129.6, 129.7, 129.9, 132.6, 136.9, 159.8, (ArC), 172.3 (CO2Me) 
ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 1739, 1612, 1552, 1517, 1494, 1455, 1436, 
1373, 1305, 1253, 1139, 1091, 1029, 981, 921, 701 cm-1; MS (EI): 
m/z 459 (M+-NO2, <2%), 446 (19), 399 (25), 250 (30), 249 (13), 
223 (100), 145 (14), 116 (19), 113 (22), 91 (15), 77 (15); HRMS 




carboxylate (10c). White solid (167 mg, 58% yield, de: 95%); 
precipitation with EtOAc:Et2O; mp: 184-189 °C; [𝛼]𝐷
28 = 68.4 (c 1, 
CHCl3); 1H NMR (300 MHz, CDCl3) δH: 3.44 (s, 3H, CO2CH3), ), 
3.84 (dd, J = 11.5, 9.8 Hz, 1H, NCHCHPh), 4.18 (d, J = 9.8 Hz, 
1H, CHCO2Me), 4.44-4.59 (m, 3H, CH2, NCHCHNO2), 4.80 (dd, J 
= 12.2, 9.3 Hz, 1H, NCHCH2NO2), 5.49 (dd, J = 11.6, 8.8 Hz, 
1H,CHNO2), 7.06-7.52 (13 H, ArH) ppm; 13C NMR (CDCl3) δC: 
50.7 (NCHCHPh), 52.5 (OCH3), 60.1 (NCHPh), 63.6 (NCHPh), 
70.3 (CCO2Me), 77.0 (CH2NO2), 91.9 (CHNO2), 128.0, 128.3, 
128.7, 129.3, 129.4, 129.7, 129.7, 130.0, 130.2, 130.4, 130.9, 
131.1, 134.9, 136.0, 136.4 (ArC), 171.9 (CO2Me) ppm; IR (ATR) 














This article is protected by copyright. All rights reserved.
FULL PAPER    
6 
 
1014, 819, 704 cm-1; MS (EI): m/z 429 (M+-NO2, <2%), 417 (16), 
416 (63), 370 (21), 369 (80), 279 (12), 221 (18), 220 (100), 219 
(36), 194 (14), 193 (80), 191 (13), 178 (19), 117 (22), 116 (16), 
115 (58), 105 (13), 104 (79), 103 (17), 102 (11), 91 (27), 77 (20); 




White solid (193 mg, 60% yield, de: 90%); precipitation with 
EtOAc:Et2O; mp: 170-172 °C; [𝛼]𝐷
28 = 74.7 (c 1, CHCl3); 1H NMR 
(300 MHz, CDCl3) δH: 3.46 (s, 3H, CO2CH3), 3.78 (dd, J = 11.3, 
10.0 Hz, 1H, NCHCHPh) 4.27 (d, J = 9.8 Hz, 1H, CHCO2Me), 
4.38-4.60 (m, 3H, CH2, NCHCHNO2), 4.85 (dd, J = 12.2, 9.4 Hz, 
1H, NCHCH2NO2), 5.49 (dd, J = 11.5, 8.8 Hz, 1H,CHNO2), 7.04-
7.56 (m, 14H, ArH) ppm; 13C NMR (CDCl3) δC: 50.6 (NCHCHPh), 
52.4 (OCH3), 60.6 (NCHPh), 63.3 (NCHPh), 70.3 (CCO2Me), 
77.18 (CH2NO2), 91.8 (CHNO2), 128.1, 128.3, 128.4, 129.2, 129.3, 
129.4, 129.5, 129.6, 129.7, 129.9, 130.0, 131.0, 132.4, 134.7, 
136.6 (ArC), 172.0 (CO2Me) ppm; IR (ATR) 𝜐𝑚𝑎𝑥 : 1731, 1547, 
1494, 1376, 1204, 1146, 1093, 1031, 1015, 839, 808, 767 cm-1; 
MS (EI): m/z 449 (M+-CH2NO2, <2%), 439 (18), 437 (25), 151 (11), 
149 (23), 139 (23), 137 (71), 135 (15), 117 (17), 116 (12), 115 
(35), 102 (20), 101 (18), 256 (25), 253 (72), 229 (32.5), 227 (100), 
219 (15), 192 (24), 191 (21), 189 (13)151 (11), 149 (23), 136 (15), 
125 (17), 116 (26), 115 (35), 102 (20), 91 (13), 77 (10); HRMS 
calcd. for: C26H25N3O6(–CO2CH3) 450.1221; found: 450.1252. 
 
 (2S,3S,4R,5S)-Methyl 4-nitro-1-[(S)-2-nitro-1-phenylethyl]-3-
phenyl-5-(p-tolyl)pyrrolidine-2-carboxylate (10e): White solid 
(144 mg, 55% yield, de: 95%); precipitation with EtOAc:Et2O; mp: 
171-172 °C; [𝛼]𝐷
26 = 50.8 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3) 
δH: 2.42 (s, 3H, PhCH3), 3.39 (s, 3H, CO2CH3), 3.78-3.88 (m, 1H, 
NCHCHPh) 4.27 (d, J = 9.9 Hz, 1H, CHCO2Me), 4.44-4.53 (m, 2H, 
CH2), 4.59 (dd, J = 9.1, 6.2 Hz, NCHCHNO2) , 4.84 (dd, J = 12.2, 
9.2 Hz, 1H, NCHCH2NO2), 5.51 (dd, J = 11.5, 8.8 Hz, 1H,CHNO2), 
7.09-7.52 (m, 14H, ArH) ppm; 13C NMR (CDCl3) δC: 21.6 (PhCH3), 
51.2 (NCHCHPh), 52.2 (OCH3), 60.5 (NCHPh), 63.5 (NCHPh), 
70.2 (CCO2Me), 77.2 (CH2NO2), 91.9 (CHNO2), 128.0, 128.4, 
128.6, 129.0, 129.7, 129.7, 130.3, 130.4, 132.6, 132.6, 134.0, 
139.8 (ArC), 172.3 (CO2Me) ppm; IR (ATR) 𝜐𝑚𝑎𝑥 : 1741, 1552, 
1453, 1434, 1369, 1199, 1141, 1025, 816 cm-1; MS (EI): m/z 443 
(M+-NO2, 2%), 431 (20), 430 (72), 384 (28), 383 (100), 235 (15), 
234 (82), 233 (44), 207 (43), 191 (13), 131 (12), 130 (11), 129 
(14), 115 (34), 104 (66), 103 (15), 91 (18); HRMS calcd. for: 
C26H25N3O6(–CO2CH3) 430.1767; found: 430.1769. 
 
(2S,3S,4R,5S)-Methyl 4-nitro-1-(3-oxobutyl)-3,5-
diphenylpyrrolidine-2-carboxylate (11): White solid (172 mg, 
78% yield); mp: 132 ºC; precipitation with EtOAc:Et2O; mp: 142-
144 ⁰C;  [𝛼]𝐷
17 = 72.0 (c 1, CHCl3);  1H NMR (300 MHz, CDCl3) δH: 
1.99 (s, 3H, COCH3), 2.61-2.41 (m, 2H, ), 3.00 (t, J = 7 Hz, 1H, ), 
3.29 (s, 3H, CO2CH3), 4.17 (d, J = 9.9 Hz, 1H, ), 4.46-4.40 (m, 
2H, ), 5.39 (dd, J = 9.9, 8.7 Hz, ), 7.27-7.56 (m, 10H, ArH) ppm; 
13C NMR (CDCl3) δC: 30.1 (COCH3), 41.6 (CH2), 47.4 (CH2), 51.2 
(NCHCHPh), 51.9 (CO2CH3), 69.5 (NCHPh), 72.8 (NCHCO2CH3), 
93.8 (CHNO2), 128.0, 128.1, 128.5, 128.9, 129.2, 129.5, 130.3, 
133.7, 134.1, 137.2 (ArC), 171.6 (CO2CH3), 206.9 (COCH3) ppm; 
IR (ATR) 𝜐𝑚𝑎𝑥: 1742, 1714, 1366, 1147 cm
-1; MS (EI): m/z 350 
(M+ -NO2, 32%), 337 (27), 291 (26), 290 (99), 233 (20), 232 (100), 




yl)propyl]-3,5-diphenylpyrrolidine-2-carboxylate (12): White 
solid (153 mg, 62% yield); mp: 150-152 ⁰C; precipitation with 
EtOAc:Et2O; [𝛼]𝐷
17 = 15.6 (c 1, CHCl3);  1H NMR (300 MHz, CDCl3) 
δH: 2.98-3.02 (m, 2H), 3.05-3.16 (m, 2H), 3.30 (s, 3H, CO2CH3), 
3.87-3.93 (m, 2H), 4.24 (d, J = 9.9 Hz, 1H), 4.30-4.34 (m, 2H), 
4.39-4.49 (m, 2H), 5.38 (dd, J = 9.9, 8.7 Hz, 1H), 7.25-7.31 (m, 
5H, ArH), 7.39-7.41 (m, 3H), 7.55-7.57 (m, 2H) ppm; 13C NMR 
(CDCl3) δC: 33.2 (NCH2CH2), 42.5 (OCNCH2), 47.5 (NCH2CH2), 
51.2 (NCHCHPh), 51.8 (CO2CH3), 62.2 (CO2CH2), 69.1 (NCHPh), 
72.4 (NCHCO2CH3), 93.4 (CHNO2), 128.1, 128.2, 128.4, 128.6, 
128.8, 129.1, 129.3, 129.4, 130.2, 134.2, 137.3 (ArC), 153.5 
(NCOO), 171.3 (CO), 171.6 (CO) ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 1794, 1743, 
1697, 1541, 1383, 1196 cm-1; MS (EI): 421 (M+ -NO2, 26%), 420 
(47), 408 (23), 361 (59), 274 (100), 232 (55), 220 (29), 193 (32), 
142 (30), 115 (44), 91 (22), 55 (25); HRMS calcd. for C24H25N3O7: 
467.1693; found: 467.1672. 
 
(2S,3S,4R,5S)-Methyl 4-nitro-1-[3-oxo-3-(2-oxopyrrolidin-1-
yl)propyl]-3,5-diphenylpyrrolidine-2-carboxylate (13): white 
solid (172 mg, 71% yield); precipitation with EtOAc:Et2O; mp: 134-
136 ⁰C; [𝛼]𝐷
17 = 18.4 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3) δH: 
1.95-1.98 (m, 2H), 2.47-2.52 (m, 2H), 2.90-2.97 (m, 1H), 3.00-
3.13 (m, 3H), 3.30 (s, 3H), 3.70 (td, J = 7.4, 1.6 Hz, 2H), 4.25 (d, 
J = 10.0 Hz, 1H), 4.38-4.46 (m, 2H), 5.37 (dd, J = 10.0, 8.5 Hz, 
1H), 7.25-7.30 (m, 5H), 7.36-7.41 (m, 3H), 7.53-7.56 (m, 2H) ppm; 
13C NMR (CDCl3) δC: 17.2 (OCNCH2CH2), 33.6 (OCNCOCH2), 
34.8 (NCH2CH2CO), 45.5 (OCNCH2CH2), 47.3 (NCH2CH2CO), 
51.2 (NCHCHPh), 51.7 (CO2CH3), 68.9 (NCHPh), 72.2 
(NCHCO2CH3), 94.0 (CHNO2), 128.0, 128.2, 128.3, 128.6, 128.8, 
129.1, 129.2, 130.2, 134.3, 137.6 (ArC), 171.7 (CO), 172.2 (CO), 
175.4 (CO) ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 1742, 1685, 1545, 1353 cm
-1; 
MS (EI): 419 (M+ -NO2, 31%), 275 (20), 274 (100), 232 (25), 220 
(25), 193 (19), 140 (23), 115 (25); HRMS calcd. for C25H27N3O6: 
465.1900; found: 465.1894. 
 
(2S,3S,4R,5S)-Methyl 1-[3,3-bis(phenylsulfonyl)propyl]-4-
nitro-3,5-diphenylpyrrolidine-2-carboxylate (14): white solid 
(242.2, 72% yield); precipitation with EtOAc:Et2O; mp: 164-166 
⁰C; [𝛼]𝐷
17 = 22.8 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3) δH: 3.30 
(s, 3H, CO2CH3), 3.61 (dd, J = 16.0, 4.6 Hz, 1H, NCH2), 3.76 (dd, 
J = 16.5, 3.2 Hz, 1H, NCH2), 4.40-4.46 (m, 2H, NCHCHPh, 
NCHCO2Me), 4.51 (d, J = 8.1 Hz, 1H, NCHPh), 4.84 (t, J = 4.1 Hz, 
1H, CH(SO2Ph)2), 5.35 (dd, J = 12.4, 4.4 Hz, 1H, CHNO2), 7.24-
7.72 (m, 20H, ArH) ppm; 13C NMR (CDCl3) δC: 48.3 (NCH2), 51.5 
(NCHCHPh), 51.9 (CH3), 69.7 (NCHPh), 72.4 (NCHCO2CH3), 
80.9 (CS), 94.5 (CHNO2), 128.2, 128.3, 128.5, 128.9, 129.1, 
129.2, 129.4, 129.8, 130.3, 133.7, 134.3, 134.6, 134.7, 137.1, 
137.3, 138.0 (ArC), 171.9 (CO) ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 1739, 1694, 
1313, 1143, 1078, 736 cm-1; MS(EI): 437 (20), 423 (14), 422 (77), 
421 (60), 363 (26), 362 (100), 330 (31), 303 (11), 302 (40), 298 
(15), 277 (31), 271 (17), 270 (68), 244 (21), 243 (25), 193 (41), 
178 (26), 115 (94), 91 (42), 77 (29); HRMS calcd. for C18H16NO2: 
278.1165; found: 278.1181. 
 
Dimethyl 2-[(2S,3S,4R,5S)-2-(methoxycarbonyl)-4-nitro-3,5-
diphenylpyrrolidin-1-yl]but-2-enedioate (15): White solid 
(185.8 mg, 73% yield); mp: 110-112 ⁰C; [𝛼]𝐷
25 = 34.6 (c 1, CHCl3); 
1H NMR (300 MHz, CDCl3) δH: 3.40 (s, 3H, CO2CH3), 3.47 (s, 3H, 
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CCHCO2Me), 4.64 (d, J = 9.2 Hz, 1H, NCHCO2Me), 5.31 (d, J = 
8.7 Hz, 1H, NCHPh), 5.71 (dd, J = 11.9, 8.7 Hz, 1H, CHNO2), 
7.23-7.25 (m, 2H, ArH), 7.34-7.36 (m, 3H, ArH), 7.39-7.45 (m, 3H, 
ArH), 7.58-7.59 (m, 2H, ArH) ppm; 13C NMR (CDCl3) δC: 50.6 
(NCHCHPh), 51.3 (CH3), 52.6 (CH3), 52.9 (CH3), 66.9 (NCHPh), 
68.3 (NCHCO2CH3), 92.0 (C=C), 92.4 (CHNO2), 127.5, 127.9, 
129.2, 129.3, 129.4, 129.6, 130.3, 136.1, 149.6, 164.7 (CO2CH3), 
166.8 (CO2CH3), 170.2 (CO2CH3) ppm; IR (ATR) 𝜐𝑚𝑎𝑥 : 1694, 
1668, 1314, 1124 cm-1; MS (EI): 279 (14), 220 (68), 194 (17), 193 
(100), 178 (13), 125 (19), 19 (62), 117 (28), 115 (45), 103 (47), 91 




diphenylpyrrolidine-2-carboxylate (16): Orange foam (145 mg, 
70% yield);  [𝛼]𝐷
25 = 54.0 (c 1, CHCl3) 1H NMR (300 MHz, CDCl3) 
δH: 1.99 (s, 3H, CHCOCH3), 3.39 (s, 3H, CO2CH3), 4.51-4.65 (m, 
2H, NCHCO2, NCHCHPh), 5.02 (d, J = 13.4 Hz, 1H NCHCHCO), 
5.20 (d, J = 8.9 Hz, 1H, NCHPh), 5.70 (dd, J = 8.9, 11.4 Hz, 1H, 
CHNO2), 7.19 (d, J = 13.4 Hz, 1H, NCHCHCO), 7.25-7.58, (m, 
10H, ArH) ppm; 13C NMR (CDCl3) δC: 28.0 (COCH3), 50.8 
(CO2CH3), 52.6 (NCHCHPh), 69.9 (CHCO2CH3), 76.8 (NCHPh), 
91.6 (CHNO2), 102.7 (C=C), 127.2, 127.8, 128.0, 129.2, 129.8, 
130.1, 130.7, 135.7, 145.5 (ArC, C=C) 170.1 (CO2CH3), 195.7 
(COCH3) ppm; MS (EI): m/z  349 (25), 348 (100), 306 (12), 288 
(33), 244 (16), 193 (11), 115 (29), 91 (13); HRMS calcd. for: 
C22H22N2O5 394.1529; found: 394.1547. 
 
(2S,3R,4R,5S)-Methyl 4-amino-1-[(S)-2-amino-1-phenylethyl]-
3,5-diphenylpyrrolidine-2-carboxylate (17): white foam (87% 
yield); precipitation with EtOAc:Et2O; mp.: 50-53 °C; [𝛼]𝐷
23 = 55.6 
(c 1, CHCl3); 1H NMR (300 MHz, CDCl3) δH: 1.66 (s, 4H, 2x NH2), 
2.73 (dd, J = 13.5, 5.1 Hz, 1H, NCHCH2NH2), 2.85-2.98 (m, 2H, 
NCHCH2NH2, NCHCHNH2), 3.21 (s, 3H, CO2CH3), 3.59 (dd, J = 
9.7, 5.1 Hz, 1H, NCHCH2NH2), 3.67 (d, J = 8.4 Hz, 1H, 
NCHCO2Me), 3.78 (dd, J = 11.2, 8.4 Hz, 1H, NCHCHPh), 4.12 (d, 
J = 10.3 Hz, 1H, NCHCHNH2), 7.10-7.51 (m, 13H, ArH), 7.74-7.82 
(m, 2H, ArH) ppm; 13C NMR (CDCl3) δC: 43.9 (NCHCH2NH2), 51.6 
(NCHCHPh), 55.1 (OCH3), 60.9 (NCHPh), 63.3 (NCHPh), 64.9 
(NCHCHNH2), 73.4 (CCO2Me), 127.6, 128.0, 128.3, 128.4, 128.5, 
128.6, 128.7, 128.7, 129.1, 136.1, 136.8, 141.5 (ArC), 174.6 
(CO2Me) ppm; IR (ATR) 𝜐𝑚𝑎𝑥 : 3296, 3216, 1739, 1455, 1265, 
1207, 1181, 1144, 1121 cm-1; MS (EI): m/z 415 (M+, <1%), 411 
(20), 386 (28), 285 (100), 208 (27), 206 (12), 118 (11), 117 (12), 
116 (11), 91 (16); HRMS calcd. for: C26H29N3O2(–CH2NH2) 




yellow solid (33 mg, 89% yield); precipitation with EtOAc:Et2O; 
mp: 211-215 °C; [𝛼]𝐷
26 = 102.5 (c 0.7, CHCl3); 1H NMR (300 MHz, 
CDCl3) δH: 1.60 (s, 2H, NH2), 2.90 (d, J = 7.2 Hz, 1H, NCHCO), 
3.08 (dd, J = 8.2, 3.8 Hz, 1H, NCHCHNH2), 3.17 (dd, J = 7.2, 3.8 
Hz, 1H, NCHCHPh), 3.51 (dd, J = 11.6, 4.0 Hz, 1H, NCHCH2), 
3.55 (d, J = 8.2 Hz, 1H, NCHCHNH2), 4.02 (dd, J = 11.6, 5.7 Hz, 
1H, NCHCH2), 4.08 (d, J = 5.7 Hz, 1H, NCHCH2), 6.40 (d, J = 4.0 
Hz, 1H, OCNH), 7.08-7.25 (m, 3H, ArH), 7.28-7.41 (m, 6H, ArH), 
7.43-7.57 (m, 6H, ArH) ppm; 13C NMR (CDCl3) δC: 46.9 
(OCNHCH2), 53.5, 62.2 (3x CHPh), 69.9 (NCHCHNH2), 73.4 
(CCO), 126.4, 127.3, 128.0, 128.2, 128.2, 128.5, 128.5, 128.9, 
129.3, 133.7, 139.4, 144.1 (ArC), 169.9 (OCNH) ppm; IR (ATR) 
𝜐𝑚𝑎𝑥: 1670, 1491, 1453, 1348, 1313, 1183, 1110, 1071, 1029, 907, 
749, 730 cm-1 ;MS (EI): m/z 383 (M+, 8%), 265 (34), 264 (100), 
248 (13), 247 (64), 208 (11), 206 (13), 161 (52), 160 (28), 130 
(16), 119 (23), 118 (17), 117 (15), 104 (20), 103 (13), 91 (19), 90 




Yellow solid (163.7 mg, 90% yield); Without purification; mp: 188 
ºC; [𝛼]𝐷
25 = 417 (c 0.6, CHCl3); 1H NMR (300 MHz, CDCl3) δH: 3.03 
(s, 3H, NCH3), 3.97 (d, J = 17.2, Hz, 1H, CH2), 4.33 (d, J = 17.2 
Hz, 1H, CH2), 4.42 (dd, J = 9.6, 6.9 Hz, 1H, NCHCHPh), 4.72 (d, 
J = 9.6 Hz, 1H, NCHCO), 5.20 (dd, J = 6.9, 4.3 Hz, 1H, CHNO2), 
5.92 (d, J = 4.3 Hz, 1H, NCHPh), 7.09-7.46 (10H, ArH) ppm; 13C 
NMR (CDCl3) δC: 33.9 (NCH3), 53.1 (NCHCHPh), 54.2 (NCHPh), 
64.2 (CH2), 64.9 (CHCO), 96.8 (CHNO2), 125.5, 127.9, 128.4, 
129.0, 129.3, 129.7, 136.7, 136.8 (ArC), 161.8 (CO), 164.6 (CO) 
ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 2925, 1666, 1554, 1451, 1329, 90 cm
-1 ;MS 
(EI): m/z 320 (25), 319 (100), 318 (25), 220 (33), 193 (28), 115 




diphenylpyrrolidine-2-carboxylate (21): White foam (126 mg, 
38% yield); [𝛼]𝐷
26 = 65.9 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3) 
δH: 1.35 (d, J = 6.6 Hz, 3H, CCH3), 3.36 (s, 3H, OCH3), 3.76 (q, J 
= 6.6 Hz, 1H, CHCl), 4.44 (dd, J = 11.9, 9.5 Hz, 1H, NCHCHPh), 
5.10 (d, J = 9.5 Hz, 1H, NCHCO2CH3), 5.62 (d, J = 8.7 Hz, 1H, 
NCHPh), 5.71 (dd, J = 11.9, 8.7 Hz, 1H, CHNO2), 7.25-7.79 (10H, 
ArH) ppm; 13C NMR (CDCl3) δC: 19.8, 49.4, 50.3, 52.3, 65.0, 66.3, 
93.3, 127.1, 127.8, 129.2, 130.0, 130.1, 130.8, 137.4, 169.1, 
171.0  ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 1745, 1662, 1560, 1364, 1210, 701 
cm-1 ;MS (EI): m/z 370 (M+-NO2, 27%), 312 (12), 310 (37), 281 
(12), 280 (62), 278 (18), 221 (18), 220 (100), 219 (15), 191 (10), 
117 (10), 116 (10), 115 (42), 90 (19); HRMS calcd. for: 
C21H21N2O3 370.121; found: 370.1201. 
 
(2S,3S,4R,5S)-Methyl 1-[(S)-2-chloropropanoyl]-4-nitro-3,5-
diphenylpyrrolidine-2-carboxylate (20): White foam (190 mg, 
57% yield); [𝛼]𝐷
26 = 6.2 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3) 
δH: (1:1 mixture of rotamers) 1.57 (d, J = 6.6 Hz, 3H, CCH3), 3.37 
(s, 1.5 H, OCH3), 3.43 (s, 1.5 H, OCH3), 4.12 (bs, 0.5 H), 4.25 (bs, 
0.5H), 4.39 (bs, 0.5 H), 4.54 (bs, 0.5 H), 5.09 (d, 0.5H), 5.32 (d, 
0.5H), 5.38 (d, 0.5H), 5.51 (d, 0.5H), 5.51 (d, 0.5H), 5.74 (m, 1H, 
CHNO2), 7.23-7.74 (10H, ArH) ppm; 13C NMR (CDCl3) δC: 
(Mixture of rotamers) 20.8, 22.0, 49.6, 50.8, 51.0, 51.5, 52.4, 52.8, 
64.3, 64.7, 66.7, 67.3, 91.5, 93.4, 126.5, 127.1, 127.8, 128.9, 
129.1, 129.3, 130.0, 136.5, 137.6, 167.5, 170.3 ppm; IR (ATR) 
𝜐𝑚𝑎𝑥: 1742, 1669, 1556, 1368, 1214, 700 cm
-1 ;MS (EI): m/z 370 
(M+-NO2, 27%), 312 (12), 310 (37), 281 (12), 280 (62), 278 (18), 
221 (18), 220 (100), 219 (15), 191 (10), 117 (10), 116 (10), 115 





Colorless oil (40 mg, 90% yield); [𝛼]𝐷
25 = 14.4 (c 1, CHCl3); 1H 
NMR (300 MHz, CDCl3) δH: 1.69 (d, J = 6.9 Hz, 3H, CHCH3), 3.03 
(s, 3H, NCH3), 4.26 (q, J = 6.9 Hz, 1H, CHCH3), 4.39 (dd, J = 9.8, 
7.0 Hz, 1 H, NCHCHPh), 4.70 (d, J = 9.8 Hz, 1H, NCHCHPh), 
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NCHPh), 7.09-7.47 (10H, ArH) ppm; 13C NMR (CDCl3) δC: 16.8 
(CHCH3), 31.2 (NCH3), 54.6 (NCHCHPh), 56.8 (NCHPh), 64.1 
(NCHCO), 65.1 (CHCH3), 96.9 (CHNO2), 125.7, 128.0, 128.5, 
129.0, 129.4, 129.7, 136.6, 136.8 (ArC), 165.0 (CO), 165.1 (CO) 
ppm; IR (ATR) 𝜐𝑚𝑎𝑥: 1666, 1555, 1453, 1364, 1079 cm
-1 ;MS (EI): 





Colorless oil (22 mg, 50% yield); [𝛼]𝐷
25 = 33.2 (c 1, CHCl3); 1H 
NMR (300 MHz, CDCl3) δH: 1.59 (d, J = 7.1 Hz, 3H, CHCH3), 3.03 
(s, 3H, NCH3), 4.03 (q, J = 7.1 Hz, 1H, CHCH3), 4.46 (dd, J = 9.4, 
7.0 Hz, 1 H, NCHCHPh), 4.68 (d, J = 9.4 Hz, 1H, NCHCHPh), 
5.17 (dd, J = 7.0, 4.4 Hz, 1H, CHNO2), 5.92 (d, J = 4.4 Hz, 1H, 
NCHPh), 7.09-7.48 (10H, ArH) ppm; 13C NMR (CDCl3) δC: 17.4 
(CHCH3), 32.2 (NCH3), 53.9 (NCHCHPh), 60.0 (NCHPh), 63.9 
(NCHCO), 64.6 (CHCH3), 96.7 (CHNO2), 125.1, 127.9, 128.3, 
128.9, 129.2, 129.7, (ArC), 164.7 (CO), 165.5 (CO) ppm; IR (ATR) 
𝜐𝑚𝑎𝑥: 1666, 1555, 1453, 1364, 1079 cm
-1; MS (EI): m/z 370 (M+-
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